Viewing Study NCT06738303


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2025-12-27 @ 7:03 PM
Study NCT ID: NCT06738303
Status: RECRUITING
Last Update Posted: 2025-08-27
First Post: 2024-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Sponsor: Case Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module